Also, the percentage of individuals for which neither molecule had no detection (under the limit of detection of 6.25 ng/mL for sHLA-G and 31.25 pg/mL for sMICA) was higher for the Ct compared to the CKD (Fig 2a and 2b). This evidence concerns the gene HLA-G and chronic kidney disease.